KDMN Chart
- 52-Week Range: $3.46 - $9.50
- Market Capitalization: $1.67B
- Short Percentage: 0%
- Target Price: $12.10
- Shares Outstanding: 178.52M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
No upcoming catalysts found
News and Press Releases
- Sanofi to acquire Kadmon to further strengthen growth of transplant businessGlobeNewsWire | September 8th
- Sanofi to acquire U.S. biopharmaceutical group Kadmon in $1.9 billion dealMarket Watch | September 8th
- France's Sanofi to buy U.S. biopharma firm Kadmon in $1.9 billion dealReuters | September 8th
- Sanofi To Acquire Kadmon To Further Strengthen Growth of Transplant BusinessAccesswire | September 8th
- Sanofi to acquire Kadmon to further strengthen growth of transplant businessGlobeNewsWire | September 8th
Company Info
Website: http://www.kadmon.com
Address: 450 East 29th Street, New York, NY, United States, 10016
Sector: Healthcare
Industry: Biotechnology
Full time employees: 127
Address: 450 East 29th Street, New York, NY, United States, 10016
Sector: Healthcare
Industry: Biotechnology
Full time employees: 127
$KDMN down hard at open
$KDMN Hold on to your Butts.
$KDMN nothing drops
$KDMN my lotto for earnings
$KDMN rocket fuel tanks are full. Gonna shoot to the stars
$KDMN has just been halted from trading.
$KDMN Love this stock.
Light taps
$KDMN take what we can get
$KDMN green is good
$KDMN very normal lol sike